Assembly Biosciences, Inc. · NASDAQ:ASMB
Okazaki Jason A sold 6,202 Assembly Biosciences, Inc. shares (Form 4)
Traded Oct 30 to Nov 2, 2026 · Filed Nov 3, 2026
From Oct 30 to Nov 2, 2026, Okazaki Jason A (Director, CEO and President) sold 6,202 Assembly Biosciences, Inc. shares at an average US$19.62 for US$122K, leaving 195,532 shares. Filed Nov 3, 2026 (Form 4).
- Sold
- 6,202 shares
- Price
- US$19.62 average (US$19.61 to US$20.35)
- Value
- US$122K
- Holding after
- 195,532 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Common Stock | Award | 38,380 | 201,734 | Direct | |
| Nov 2, 2026 | Common Stock | Sale | 6,133 | US$19.61 | 195,601 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 69 | US$20.35 | 195,532 | Direct |
Source
Download original · View original at SEC
Related
- Assembly Biosciences, Inc.
- Okazaki Jason A
- Assembly Biosciences, Inc. shareholders
- Form 4 · Okazaki Jason A · Jun 5, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Gaggar Anuj · Nov 3, 2026
- Form 4 · White Nicole S · Nov 3, 2026
- Form 4 · Bjorkquist Jeanette M · Nov 3, 2026
- Form 4 · Delaney William E IV · Nov 3, 2026